Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Cytotoxic Chemotherapy in Older Women
2005-005721-55Phase 4Terminated
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Feb 2008
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of doxorubicin, epirubicin and cyclophosphamide in breast cancer (2 arms), sponsored by Imperial College Healthcare NHS Trust. Primary endpoint: Relapse-Free Interval. Started Feb 2008; status: terminated.
02
Drugs
doxorubicinepirubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-005721-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005721-55.